Position in DNA
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$14,591,186
+$6,336,167 QoQ
Shares Held
1,472,370
+9.3% QoQ
Ownership
2.19%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 183 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 20%
Shared 0%
None 80%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STATE STREET CORP holds $36,552,510,511 across 411 Biotechnology names. DNA ranks #176 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,871,459 | $5,896,909,829 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,834,688 | $3,014,621,355 | |
| 3 | INCY |
Incyte Corp
|
9,722,336 | $1,102,124,008 | |
| 4 | MRNA |
Moderna, Inc.
|
15,726,193 | $1,101,305,295 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,555,689 | $1,070,369,059 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
4,897,051 | $917,119,711 | |
| 7 | RPRX |
Royalty Pharma plc
|
12,338,229 | $691,804,500 | |
| 8 | INSM |
INSMED Inc
|
6,052,174 | $645,282,791 |
All Filings in DNA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,591,186 | 1,472,370 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $8,255,019 | 1,346,659 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $10,737,110 | 1,292,071 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $13,615,387 | 933,840 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $8,336,835 | 741,052 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,911,609 | 335,370 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,345,300 | 238,829 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,760,571 | 216,021 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,370,950 | 10,092,665 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $30,839,173 | 26,585,494 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $44,030,661 | 26,053,646 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $40,641,262 | 22,453,736 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $38,471,778 | 20,683,752 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $19,560,985 | 14,707,508 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $23,502,028 | 13,906,526 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $41,154,940 | 13,190,686 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $29,540,214 | 12,411,855 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $16,120,274 | 4,000,068 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $31,558,596 | 3,797,665 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||